Literature DB >> 21220432

E3 ligase STUB1/CHIP regulates NAD(P)H:quinone oxidoreductase 1 (NQO1) accumulation in aged brain, a process impaired in certain Alzheimer disease patients.

Peter Tsvetkov1, Yaarit Adamovich, Evan Elliott, Yosef Shaul.   

Abstract

NAD(P)H:quinone oxidoreductase 1 (NQO1) is a flavoenzyme that is important in maintaining the cellular redox state and regulating protein degradation. The NQO1 polymorphism C609T has been associated with increased susceptibility to various age-related pathologies. We show here that NQO1 protein level is regulated by the E3 ligase STUB1/CHIP (C terminus of Hsc70-interacting protein). NQO1 binds STUB1 via the Hsc70-interacting domain (tetratricopeptide repeat domain) and undergoes ubiquitination and degradation. We demonstrate here that the product of the C609T polymorphism (P187S) is a stronger STUB1 interactor with increased susceptibility to ubiquitination by the E3 ligase STUB1. Furthermore, age-dependent decrease of STUB1 correlates with increased NQO1 accumulation. Remarkably, examination of hippocampi from Alzheimer disease patients revealed that in half of the cases examined the NQO1 protein level was undetectable due to C609T polymorphism, suggesting that the age-dependent accumulation of NQO1 is impaired in certain Alzheimer disease patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21220432      PMCID: PMC3058985          DOI: 10.1074/jbc.M110.193276

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  57 in total

1.  Susceptibility of p53 unstructured N terminus to 20 S proteasomal degradation programs the stress response.

Authors:  Peter Tsvetkov; Nina Reuven; Carol Prives; Yosef Shaul
Journal:  J Biol Chem       Date:  2009-07-17       Impact factor: 5.157

2.  Differential gene expression profiles in the hippocampus of senescence-accelerated mouse.

Authors:  Xiao-Rui Cheng; Wen-Xia Zhou; Yong-Xiang Zhang; Dong-Sheng Zhou; Rui-Fu Yang; Ling-Feng Chen
Journal:  Neurobiol Aging       Date:  2006-03-29       Impact factor: 4.673

3.  The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins.

Authors:  Chad A Dickey; Adeela Kamal; Karen Lundgren; Natalia Klosak; Rachel M Bailey; Judith Dunmore; Peter Ash; Sareh Shoraka; Jelena Zlatkovic; Christopher B Eckman; Cam Patterson; Dennis W Dickson; N Stanley Nahman; Michael Hutton; Francis Burrows; Leonard Petrucelli
Journal:  J Clin Invest       Date:  2007-02-15       Impact factor: 14.808

4.  NAD(P)H quinone oxidoreductase 1 inhibits the proteasomal degradation of the tumour suppressor p33(ING1b).

Authors:  Marco Garate; Ronald P C Wong; Eric I Campos; Yemin Wang; Gang Li
Journal:  EMBO Rep       Date:  2008-04-04       Impact factor: 8.807

5.  BAG-1M is up-regulated in hippocampus of Alzheimer's disease patients and associates with tau and APP proteins.

Authors:  Evan Elliott; Offir Laufer; Irith Ginzburg
Journal:  J Neurochem       Date:  2009-03-20       Impact factor: 5.372

6.  Chaperone-dependent stabilization and degradation of p53 mutants.

Authors:  P Muller; R Hrstka; D Coomber; D P Lane; B Vojtesek
Journal:  Oncogene       Date:  2008-01-28       Impact factor: 9.867

7.  Quinone reductase acts as a redox switch of the 20S yeast proteasome.

Authors:  Sonja Sollner; Markus Schober; Andrea Wagner; Anna Prem; Lucie Lorkova; Bruce A Palfey; Michael Groll; Peter Macheroux
Journal:  EMBO Rep       Date:  2008-11-21       Impact factor: 8.807

8.  CHIP regulates leucine-rich repeat kinase-2 ubiquitination, degradation, and toxicity.

Authors:  Han Seok Ko; Rachel Bailey; Wanli W Smith; Zhaohui Liu; Joo-Ho Shin; Yun-Il Lee; Yong-Jie Zhang; Haibing Jiang; Christopher A Ross; Darren J Moore; Cam Patterson; Leonard Petrucelli; Ted M Dawson; Valina L Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-05       Impact factor: 11.205

9.  Association of NAD(P)H:quinone oxidoreductase 1 polymorphism and Alzheimer's disease in Chinese.

Authors:  Jian-Tao Bian; Hua-Lu Zhao; Zhen-Xin Zhang; Xiu-Hua Bi; Jun-Wu Zhang
Journal:  J Mol Neurosci       Date:  2008-02-06       Impact factor: 3.444

10.  The ubiquitin ligase CHIP acts as an upstream regulator of oncogenic pathways.

Authors:  Masashi Kajiro; Ryuichi Hirota; Yuka Nakajima; Kaori Kawanowa; Kae So-ma; Ichiaki Ito; Yuri Yamaguchi; Sho-hei Ohie; Yasuhito Kobayashi; Yuko Seino; Miwako Kawano; Yoh-ichi Kawabe; Hiroyuki Takei; Shin-ichi Hayashi; Masafumi Kurosumi; Akiko Murayama; Keiji Kimura; Junn Yanagisawa
Journal:  Nat Cell Biol       Date:  2009-02-08       Impact factor: 28.824

View more
  27 in total

1.  Activation of the nuclear factor E2-related factor 2/antioxidant response element pathway is neuroprotective after spinal cord injury.

Authors:  Xiaoliang Wang; Juan Pablo de Rivero Vaccari; Handong Wang; Paulo Diaz; Ramon German; Alex E Marcillo; Robert W Keane
Journal:  J Neurotrauma       Date:  2011-09-21       Impact factor: 5.269

2.  Curcumin Monoglucoside Shows Improved Bioavailability and Mitigates Rotenone Induced Neurotoxicity in Cell and Drosophila Models of Parkinson's Disease.

Authors:  M D Pandareesh; M K Shrivash; H N Naveen Kumar; K Misra; M M Srinivas Bharath
Journal:  Neurochem Res       Date:  2016-08-17       Impact factor: 3.996

3.  The Ontogeny and Population Variability of Human Hepatic NADPH Dehydrogenase Quinone Oxido-Reductase 1 (NQO1).

Authors:  Luc R A Rougée; Zoe Riches; Jacob M Berman; Abby C Collier
Journal:  Drug Metab Dispos       Date:  2016-02-08       Impact factor: 3.922

4.  Phosphorylation of CHIP at Ser20 by Cdk5 promotes tAIF-mediated neuronal death.

Authors:  C Kim; N Yun; J Lee; M B H Youdim; C Ju; W-K Kim; P-L Han; Y J Oh
Journal:  Cell Death Differ       Date:  2015-07-24       Impact factor: 15.828

5.  miR-100 antagonism triggers apoptosis by inhibiting ubiquitination-mediated p53 degradation.

Authors:  G Yang; Y Gong; Q Wang; L Wang; X Zhang
Journal:  Oncogene       Date:  2016-08-15       Impact factor: 9.867

6.  AAV/BBB-Mediated Gene Transfer of CHIP Attenuates Brain Injury Following Experimental Intracerebral Hemorrhage.

Authors:  Shuo Zhang; Zheng-Wei Hu; Hai-Yang Luo; Cheng-Yuan Mao; Mi-Bo Tang; Yu-Sheng Li; Bo Song; Yao-He Wang; Zhong-Xian Zhang; Qi-Meng Zhang; Li-Yuan Fan; Yao Zhang; Wen-Kai Yu; Chang-He Shi; Yu-Ming Xu
Journal:  Transl Stroke Res       Date:  2019-07-19       Impact factor: 6.829

7.  Recognition of enzymes lacking bound cofactor by protein quality control.

Authors:  Adrián Martínez-Limón; Marion Alriquet; Wei-Han Lang; Giulia Calloni; Ilka Wittig; R Martin Vabulas
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-12       Impact factor: 11.205

Review 8.  Tuning the proteasome to brighten the end of the journey.

Authors:  Thibault Mayor; Michal Sharon; Michael H Glickman
Journal:  Am J Physiol Cell Physiol       Date:  2016-09-07       Impact factor: 4.249

9.  NAD(P)H:quinone oxidoreductase 1 (NQO1) localizes to the mitotic spindle in human cells.

Authors:  David Siegel; Jadwiga K Kepa; David Ross
Journal:  PLoS One       Date:  2012-09-11       Impact factor: 3.240

10.  Expression of Quinone Reductase-2 in the Cortex Is a Muscarinic Acetylcholine Receptor-Dependent Memory Consolidation Constraint.

Authors:  Akiva N Rappaport; Eyal Jacob; Vijendra Sharma; Sharon Inberg; Alina Elkobi; Hadile Ounallah-Saad; Metsada Pasmanik-Chor; Efrat Edry; Kobi Rosenblum
Journal:  J Neurosci       Date:  2015-11-25       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.